Florento Leila, Matias Ronald, Tuaño Elena, Santiago Katherine, Dela Cruz Frederick, Tuazon Alexander
Department of Biological Sciences, Medical and Regulatory Affairs Division, United Laboratories, Inc., 66 United St. Mandaluyong City, Philippines.
Int J Biomed Sci. 2012 Mar;8(1):76-80.
Chemotherapy is the main treatment modality for certain types of cancer. It is important to monitor and ensure that these chemotherapeutic drugs are potent and effective prior to patient administration. The objective of the study is to evaluate the cytotoxic activity and potency of selected commercially available generic anticancer drugs in comparison with originator using various human cancer cell lines in an in vitro cell-based assay. Half-maximal inhibitory concentration (IC50) of the different chemotherapeutic agents was obtained from an experimentally derived dose-response curve. Relative potency of the drugs was estimated according to Parallel Line assay. This study demonstrated that the selected generic oncology products tested had similar efficacy compared with the originator. Both products showed comparable results as shown both in vitro cytotoxicity assay and statistical analysis. In vitro cell-based cytotoxicity assay promises to be a useful, reliable and rapid method for demonstrating chemotherapeutic drug activity.
化疗是某些类型癌症的主要治疗方式。在给患者用药之前,监测并确保这些化疗药物有效且药力强劲非常重要。本研究的目的是通过体外细胞实验,使用多种人类癌细胞系,评估所选市售仿制药抗癌药物与原研药相比的细胞毒性活性和药力。不同化疗药物的半数最大抑制浓度(IC50)是从实验得出的剂量反应曲线中获得的。根据平行线分析评估药物的相对药力。本研究表明,所测试的所选仿制药肿瘤产品与原研药具有相似的疗效。两种产品在体外细胞毒性试验和统计分析中均显示出可比的结果。体外细胞毒性试验有望成为一种用于证明化疗药物活性的有用、可靠且快速的方法。